Trial Site Detail
Drug: |
CB-839 |
|||
|---|---|---|---|---|
Trial: |
Study of the Glutaminase Inhibitor CB-839 in Solid Tumors |
|||
| Conditions: | Solid Tumors | |||
Trial Status: |
Active, not recruiting |
|||
National Cancer InstituteBuilding 10, Room 4-3760 10 Center Drive |
Principal Investigator: |
Ramaprasad Srinivasan, MD |
|---|---|
Contact: |
Geri Hawks, RN 301-402-7913 ghawks@mail.nih.gov Contact: Ramaprasad Srinivasan, MD 301-451-2298 ramasrin@mail.nih.gov |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
National Cancer Institute Website: |
http://www.cc.nih.gov/index.html |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.